• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-1TH190
Device Problem Contamination (1120)
Patient Problem Unspecified Infection (1930)
Event Date 10/02/2020
Event Type  Injury  
Event Description
The customer reported after being notified by the state board of health, a cluster of six gastroenterology patients have been diagnosed with the same strain of carbapenemase-producing pseudomonas aeruginosa (cppa) during a six-month period.All six patients were found to have undergone procedures using the same evis exera iii gastrointestinal videoscope.Patient 1 of 6 is reported in case with patient identifier (b)(6).Patient 2 of 6 is reported in case with patient identifier (b)(6).Patient 3 of 6 is reported in case with patient identifier (b)(6).Patient 4 of 6 is reported in case with patient identifier (b)(6).Patient 5 of 6 is reported in case with patient identifier (b)(6).Patient 6 of 6 is reported in case with patient identifier (b)(6).In this patient case: eight days after an endoscopic ultrasound (eus)/esophagogastroduodenoscopy (egd) with stent placement using an evis exera iii gastrointestinal videoscope, the patient had blood culture results showing: pseudomonas aeruginosa, carbapenem resistant (carbapenemase producer).The patient required unspecified treatment due to the infection.The indication for the procedure was malignant tumor of the head of pancreas, gastric outlet obstruction, duodenal stenting, and staging of malignant ascites.The patients history was significant for: metastatic pancreatic adenocarcinoma, gastric outlet obstruction, diabetes mellitus (dm), and admission from hospice care for vancomycin resistant enterococcus (vre) bacteremia.The patients current condition is reported as deceased.The patients cause of death is not known to be associated with the device at this time.Cause of death has been requested, but not provided at the time of this report.The customer verified there was no malfunction of the olympus scope during the procedure.The customer reports after becoming aware of these events, the scope was immediately quarantined.The suspect scope was cultured, and all cultures were negative for pseudomonas aeruginosa.The customer also reports the suspect scope was carefully examined with no abnormalities noted.No breaches were found from standard high-level disinfection processes.
 
Event Description
Correction to g3 of the initial medwatch.The aware date should be 23-jun-2021.
 
Event Description
This supplemental report is being submitted to update section b2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key12180793
MDR Text Key261948662
Report Number2951238-2021-00364
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170343360
UDI-Public04953170343360
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/23/2021,12/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-1TH190
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date06/23/2021
Event Location Hospital
Date Report to Manufacturer06/23/2021
Date Manufacturer Received07/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
MEDIVATOR AER.; MEDIVATOR AER
Patient Outcome(s) Required Intervention; Other; Death;
Patient Age60 YR
Patient SexFemale
Patient Weight68 KG
-
-